Actively Recruiting
Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric
Led by Medical University of Vienna · Updated on 2025-05-14
750
Participants Needed
1
Research Sites
466 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigational devices are approved intraocular lenses (IOL) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Within the study, three different IOLs will be investigated and separately evaluated. Cataract surgery with IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be postoperative refraction, visual acuity, slitlamp examination, and rotation of the IOL within 1 hour, 1 week, 1 month and 4-7 months. In the Alcon Clareon toric, RayOne EMV toric and PODEYE Toric group, patients receive a toric IOL according to their preoperative astigmatism
CONDITIONS
Official Title
Rotation of Hydrophobic Acrylic Lenses - Rayner RA0800C & Alcon Clareon & Hoya Nanex & Hoya Vivinex XY1-EM & RayOne EMV Toric & PODEYE Toric
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Uni- or bilateral age-related cataract requiring phacoemulsification and posterior IOL implantation
- Age between 45 and 95 years
- Spherical IOL correction needed between 10.00 and 30.00 diopters
- For Alcon Clareon toric group, spherical correction between +6.00 and +30.00 diopters
- For Rayner RayOne EMV toric group, spherical correction between +10.00 and +25.00 diopters
- Pupil dilation in mydriasis at least 7.0 mm for Hoya and Rayner groups
- Astigmatism of at least 1.0 diopters for Alcon Clareon toric, Rayner RayOne EMV toric, and PODEYE Toric groups
- Pupil dilation greater than 5.5 mm for Alcon Clareon toric and Rayner RayOne EMV toric groups
You will not qualify if you...
- Previous eye surgery or eye trauma
- Recurrent intraocular inflammation of unknown cause
- Uncontrolled glaucoma
- Uncontrolled systemic or eye disease
- Blindness in the other eye
- Microphthalmus
- Corneal abnormalities such as scarring
- History of uveitis or iritis
- Iris neovascularization
- Proliferative diabetic retinopathy
- Pregnancy
- Breastfeeding
- Women of childbearing age must confirm pregnancy is not possible
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medical University of Vienna Allgemeines Krankenhaus
Vienna, State of Vienna, Austria, 1090
Actively Recruiting
Research Team
R
Rupert Menapace, Prof.Dr.
CONTACT
D
Daniel Schartmueller, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here